Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine (Q36900337)
Jump to navigation
Jump to search
scientific article published on December 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine |
scientific article published on December 1998 |
Statements
1 reference
Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine (English)
1 reference
Kimura I
1 reference
Kawasaki M
1 reference
Matsuda A
1 reference
Kataoka M
1 reference
Kokurba Y
1 reference
1 December 1998
1 reference
1 reference
48
1 reference
12
1 reference
1163-1167
1 reference
Identifiers
1 reference